Liver diagnostics

BioPredictive has a wide variety of non-invasive diagnostic tests for liver disease at its disposal.

Each of our tests is designed with the same philosophy and the same rigor in order to offer a high-quality service with complete safety and confidence.

These easy-to-implement tests involve taking a blood sample and result in an user-friendly, illustrated results sheet.

FibroTest™

Assessment of hepatic fibrosis or cirrhosis of the liver

Find out more  

ActiTest™

Estimates the level of liver inflammation.

Find out more  

SteatoTest™

It estimates the extent of hepatic steatosis (fatty liver deposits), which is a frequent cause of high Gamma-GT and transaminase levels.

Find out more  

NashTest™

Identifies non-alcoholic steatohepatitis (NASH) in insulin-resistant, overweight, diabetic, or hyperlipidemic patients.

Find out more  

AshTest™

Estimates the level of alcoholic steato-hepatitis (ASH) in patients who consume excess volumes of alcohol

Find out more  

« FibroTest is more effective and less costly than liver biopsy. »

Liu S et al, Plos One 2011 1

Choosing the right diagnostic test

BioPredictive's two diagnostic tests are grouped into two ranges:

  • FibroTest-ActiTest, often indicated in the viral hepatitis B and C ;

  • there are often indicators for FibroMax in subjects presenting with metabolic conditions: alcohol, excess weight, arterial hypertension, diabetes, abnormal triglyceride or cholesterol levels.

FibroTest-ActiTest

FibroMax

FibroTest
ActiTest
SteatoTest
NashTest
AshTest
Learn more Learn more

References

  1. Liu S, Schwarzinger M, Carrat F, Goldhaber-Fiebert JD. Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS ONE 2011;6:12. abstract article